Pharmacologic strategies for the treatment of meningeal malignancy

Investigational New Drugs

Volumn 14, Issue 1, 1996, Pages 69-85

  Blaney, Susan M ^a,b   Poplack, David G ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S CANCER CENTER   (United States)

Author keywords

Intrathecal; Intraventricular; Meningeal malignancies; Ommaya reservoir; Pharmacology

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; CARBOPLATIN; CARMUSTINE; CISPLATIN; CLADRIBINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DEXAMETHASONE; DIAZIQUONE; EPIPODOPHYLLOTOXIN; FLUOROURACIL; IFOSFAMIDE; IMMUNOTOXIN; MAFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; THIOTEPA; TOPOTECAN; VINCA ALKALOID;

ADOLESCENT; ARACHNOIDITIS; CANCER CHEMOTHERAPY; CHILD; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG TARGETING; GENE THERAPY; HEADACHE; HUMAN; INFANT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LEUKEMIC MENINGITIS; MAJOR CLINICAL STUDY; META ANALYSIS; NEUROTOXICITY; PARAPLEGIA; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SEIZURE; SUSTAINED RELEASE PREPARATION;

EID: 0029809836     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00173684     Document Type: Review

References (11)

1. Nugent J, Bunn PJ, Matthews M, Ihde D, Cohen M, Gazda RA, Minna J: CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 44:1885-1883, 1979
2. Mayer R, Berkowitz R, Griffiths C: Central nervous system involvement by ovarian carcinoma: a complication of prolonged survival with metastatic disease. Proc Ann Meet Assoc Cancer Res Am Soc Clin Oncol 19:318, 1978
3. Rosen S, Aisner J, Makuch R, Matthews M, Ihde D, Whitacre M, Glatstein E, Wiernik P, Lichter A, Bunn PJ: Carcinomatous leptomeningitis in small cell lung cancer: a clinocipathologic review of the National Cancer Institute experience. Medicine 61:45-53, 1982
4. Yap H, Yap B, Tashima C, DiStefano A, Blumenschein G: Meningeal carcinomatosis in breast cancer. Cancer 42:283-286, 1978
5. Poplack D, Riccardi R: Pharmacologic approaches to the treatment of central nervous system malignancy. In: Poplack D, Massimo L, Cornaglia-Ferraris P (eds) The Role of Pharmacology in Pediatric Oncology. Martinus Nijhoff, Boston, 1987, pp 137-156
6. Colling J: Regional therapy: an overview. In: Poplack D, Massimo L, Cornaglia-Ferraris P (eds) The Role of Pharmacology in Pediatric Oncology. Martinus Nijhoff, Boston, 1987, pp 125-135
7. Poplack D, Bleyer W, Horowitz M: Pharmacology of antineoplastic agents in cerebrospinal fluid. In: Wood J (ed) Neurobiology of Cerebrospinal Fluid. Plenum Press, New York, 1980, pp 561-578
8. Blasberg R, Patlak C, Fernstermacher J: Intrathecal chemotherapy. Brain tissue profiles after ventriculo-cisternal perfusion. J Pharm Exp Therap 195:73-83, 1976
9. Larson S, Schall G, DiChiro G: The influence of previous lumbar puncture and pneumoencephalography on the incidence of unsuccessful radioisotope cisternography. J Nuclear Med 12:555-557, 1981
10. Sullivan M, Vietti T, Fernbach D, Griffith K, Haddy T, Watkins W: Clinical investigations in the treatment of meningeal leukemia: radiation therapy regimens vs conventional intrathecal methotrexate. Blood 34:301- 319, 1969
11. Duttera M, Bleyer W, Pomeroy T, Leventhal C, Leventhal B: Irradiation, methotrexate toxicity, and the treatment of meningeal leukemia. Lancet 2:703-707, 1973